A Nacereddine, A Bollacke, E Róka, C Marminon… - Pharmaceuticals, 2018 - mdpi.com
Since the approval of imatinib in 2001, kinase inhibitors have revolutionized cancer
therapies. Inside this family of phosphotransferases, casein kinase 2 (CK2) is of great …